PMCB
PharmaCyte Biotech, Inc. Common StockstockNASDAQ
Market OpenNov 18, 2026 2:40:09 PM EST
5.49USD+1.384%(+0.07)186
PMCB Financials
In Q1 FY 2027 (ended ), PharmaCyte Biotech, Inc. Common Stock (PMCB) reported revenue of $0, net income of −$5.08M, operating cash flow of −$780.89K, and assets of $36.71M (filed ).
Loading financial statements…